ARTBIO
PrivateLast Round
Series B
Jul 29, 2025
Total Funding Raised
$245M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
ARTBIO is a biotechnology company that develops targeted alpha radioligand therapies for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ARTBIO Comparables
Compare ARTBIO with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aktis Oncology | 88% | |
| Ratio Therapeutics Inc. | 88% | |
| Eli Lilly and Company | 81% | |
ARTBIO Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 29, 2025 | ||||
| Series A | Dec 7, 2023 | ||||
| Seed | Jun 21, 2023 |
ARTBIO Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Omega Funds | Series B, Series A, Seed |
| B Capital Group | Series B |
| F-Prime Capital | Series A, Seed |
| Alexandria Venture Investments | Series B |
| F-Prime Capital | Series B, Series A, Seed |
| Radforsk | Seed |
| Sofinnova Investments | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Lead program AB001 is in first-in-human trials.
- Jul 29, 2025
$132M round closed.
ARTBIO Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ARTBIO's valuation, stock price, and market status.